SHE — Shedir Pharma Srl Unipersonale Income Statement
0.000.00%
Last trade - 00:00
- €40.49m
- €37.36m
- €53.48m
- 93
- 88
- 41
- 88
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 46.9 | 50.2 | 43 | 44.7 | 53.5 |
Cost of Revenue | |||||
Gross Profit | 31.1 | 30.9 | 25.4 | 25.8 | 30.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 37.5 | 44.9 | 37.1 | 38.8 | 45.2 |
Operating Profit | 9.34 | 5.27 | 5.97 | 5.91 | 8.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 9.12 | 4.91 | 5.31 | 5.7 | 8.24 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6.55 | 2.87 | 3.96 | 3.95 | 5.95 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 6.51 | 2.84 | 3.93 | 3.92 | 5.92 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 6.51 | 2.84 | 3.93 | 3.92 | 5.92 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.58 | 0.401 | 0.394 | 0.319 | 0.447 |
Dividends per Share |